These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 17443290
1. Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation? Kremer S, Pinel S, Védrine PO, Bressenot A, Robert P, Bracard S, Plénat F. J Neurooncol; 2007 Jun; 83(2):111-9. PubMed ID: 17443290 [Abstract] [Full Text] [Related]
2. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. Varallyay P, Nesbit G, Muldoon LL, Nixon RR, Delashaw J, Cohen JI, Petrillo A, Rink D, Neuwelt EA. AJNR Am J Neuroradiol; 2002 Apr; 23(4):510-9. PubMed ID: 11950637 [Abstract] [Full Text] [Related]
3. Evaluation of tumoral enhancement by superparamagnetic iron oxide particles: comparative studies with ferumoxtran and anionic iron oxide nanoparticles. Brillet PY, Gazeau F, Luciani A, Bessoud B, Cuénod CA, Siauve N, Pons JN, Poupon J, Clément O. Eur Radiol; 2005 Jul; 15(7):1369-77. PubMed ID: 15726379 [Abstract] [Full Text] [Related]
4. [MRI monitoring ultra-small superparamagnetic iron oxide (USPIO) particle labeling C6 rat glioma cells]. Zhang GX, Li YJ, Zhang F, Zhao JL, Li KA, Hu YS. Zhonghua Yi Xue Za Zhi; 2007 Jan 23; 87(4):228-32. PubMed ID: 17425864 [Abstract] [Full Text] [Related]
5. Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment. Claes A, Gambarota G, Hamans B, van Tellingen O, Wesseling P, Maass C, Heerschap A, Leenders W. Int J Cancer; 2008 May 01; 122(9):1981-6. PubMed ID: 18081012 [Abstract] [Full Text] [Related]
6. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. Enochs WS, Harsh G, Hochberg F, Weissleder R. J Magn Reson Imaging; 1999 Feb 01; 9(2):228-32. PubMed ID: 10077018 [Abstract] [Full Text] [Related]
7. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuwelt EA, Várallyay P, Bagó AG, Muldoon LL, Nesbit G, Nixon R. Neuropathol Appl Neurobiol; 2004 Oct 01; 30(5):456-71. PubMed ID: 15488022 [Abstract] [Full Text] [Related]
8. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling. Yancy AD, Olzinski AR, Hu TC, Lenhard SC, Aravindhan K, Gruver SM, Jacobs PM, Willette RN, Jucker BM. J Magn Reson Imaging; 2005 Apr 01; 21(4):432-42. PubMed ID: 15779033 [Abstract] [Full Text] [Related]
9. High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide. Christoforidis GA, Yang M, Kontzialis MS, Larson DG, Abduljalil A, Basso M, Yang W, Ray-Chaudhury A, Heverhagen J, Knopp MV, Barth RF. Invest Radiol; 2009 Jul 01; 44(7):375-83. PubMed ID: 19448552 [Abstract] [Full Text] [Related]
10. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10. Islam T, Wolf G. Cancer Biomark; 2009 Jul 01; 5(2):69-73. PubMed ID: 19414923 [Abstract] [Full Text] [Related]
11. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research. Simon GH, Raatschen HJ, Wendland MF, von Vopelius-Feldt J, Fu Y, Chen MH, Daldrup-Link HE. Acad Radiol; 2005 Sep 01; 12(9):1190-7. PubMed ID: 16099684 [Abstract] [Full Text] [Related]
13. Histologic Distribution and Characteristics on MR Imaging of Ultrasmall Superparamagnetic Iron Oxide in Ethyl-nitrosourea-induced Endogenous Rat Glioma. Yamamoto A, Takaki K, Morikawa S, Murata K, Ito R. Magn Reson Med Sci; 2021 Sep 01; 20(3):264-271. PubMed ID: 32830172 [Abstract] [Full Text] [Related]
15. Splenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observations. Harisinghani MG, Saini S, Weissleder R, Rubin D, deLange E, Harms S, Weinreb J, Small W, Sukerkar A, Brown JJ, Zelch J, Lucas M, Morris M, Hahn PF. J Comput Assist Tomogr; 2001 Sep 01; 25(5):770-6. PubMed ID: 11584239 [Abstract] [Full Text] [Related]
16. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning. Simon GH, Bauer J, Saborovski O, Fu Y, Corot C, Wendland MF, Daldrup-Link HE. Eur Radiol; 2006 Mar 01; 16(3):738-45. PubMed ID: 16308692 [Abstract] [Full Text] [Related]
18. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Moore A, Marecos E, Bogdanov A, Weissleder R. Radiology; 2000 Feb 01; 214(2):568-74. PubMed ID: 10671613 [Abstract] [Full Text] [Related]
19. Iron particles enhance visualization of experimental gliomas with high-resolution sonography. Nolte I, Vince GH, Maurer M, Herbold C, Goldbrunner R, Solymosi L, Stoll G, Bendszus M. AJNR Am J Neuroradiol; 2005 Feb 01; 26(6):1469-74. PubMed ID: 15956517 [Abstract] [Full Text] [Related]
20. Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors. Taschner CA, Wetzel SG, Tolnay M, Froehlich J, Merlo A, Radue EW. AJR Am J Roentgenol; 2005 Dec 01; 185(6):1477-86. PubMed ID: 16304001 [Abstract] [Full Text] [Related] Page: [Next] [New Search]